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A stretch of purine residues, the polypurine tract (PPT), is found in all retroviruses and is used to initiate plus-strand DNA
synthesis. While the PPT of most lentiviruses is a homogeneous sequence of purine residues, the PPT of some isolates of
the human and simian immunodeficiency viruses is interrupted with a single pyrimidine residue. The ROD strain of human
immunodeficiency virus type 2 (HIV-2) has such a pyrimidine-containing variant PPT. Virus generated from an infectious
molecular clone, pROD10, was used to infect two CD4-positive T-cell lines, H9 and CEM. The sequence of the PPT was
determined after two passages. From both cell lines, the variant PPT was retained, demonstrating that the presence of a
pyrimidine in the PPT was fully functional and that there was no strong selection for an all-purine PPT. q 1997 Academic Press
The infectious cycle of retroviruses involves a compli- comb and Hughes, 1992). This primer is then extended
to the end of the RNA template. Following the first (minus-cated series of events that begins with the interaction of
the virus with its cellular receptor(s) and results in the strand) transfer and elongation, the primer for the plus-
strand DNA is generated by specific RNaseH cleavageproduction of infectious virions (for reviews see Coffin,
1996; Luciw, 1996; Weiss et al., 1984). Following fusion of the genomic RNA, which is now part of a duplex with
the minus-strand DNA. The primer derives from a purine-of the retrovirus envelope with the cellular membrane,
the nucleocapsid core is released into the cytoplasm. rich sequence, the polypurine tract (PPT). The PPT is
located just upstream of U3 in the RNA genome (and ofThe single-stranded RNA genome, which is flanked by
the 3* LTR in the proviral genome) and is required forshort terminal repeats (termed R), is reverse transcribed
the replication of retroviruses (Sorge and Hughes, 1982)into double-stranded linear DNA, in the process duplicat-
and retrotransposons (Lauermann et al., 1995). The cor-ing elements at each end of the viral RNA to form the
rect position of the cleavage downstream of the PPT islong terminal repeat (LTR) elements, which are found at
critical, since it determines, together with the removal ofeach end of the viral DNA (Fig. 1). It is this two-LTR linear
the primer, the sequence of the inverted repeat at themolecular that is the precursor to integration into the
left end of the viral DNA. This repeat is required in cishost cell genome (for reviews see Coffin, 1996; Luciw,
by the viral integrase protein to insert the viral genome1996; Whitcomb and Hughes, 1992). As with other DNA
into the host genome (Roth et al., 1989; Varmus andpolymerases, the reverse transcriptase (RT) of human
Brown, 1989). HIV and some other retroviruses have aimmunodeficiency virus (HIV) requires a primer to initiate
second polypurine tract, PPT2, located near the centerDNA synthesis, and as with other retroviruses, HIV uses
of the genome (Guyader et al., 1987; Ratner et al., 1985;a host cell tRNA to prime minus-strand DNA synthesis.
Sanchez-Pescador et al., 1985; Wain-Hobson et al., 1985)In the case of the lentiviruses, including HIV-1 and HIV-
that enhances viral replication (Charneau et al., 1992,2, this is usually tRNALys3 (Myers et al., 1995), although
1994; Hungnes et al., 1992). For clarity, we refer to theother tRNA species can be used in vivo (Lauermann et
PPT upstream of U3 as PPT1 (Fig. 1).al., 1996) or in vitro (Wakefield et al., 1996). The 3* 18
Several biochemical studies (Powell and Levin, 1996;nucleotides of the tRNA anneal to a complementary se-
Rattray and Champoux, 1987, 1989) have been con-quence in the genomic RNA just downstream of U5 in a
ducted to measure the precision of RNaseH cleavageregion called the primer binding site (PBS; for reviews
and the subsequent extension from mutated polypurinesee (Coffin, 1996; Luciw, 1996; Weiss et al., 1984; Whit-
tracts using the MoMLV and HIV-1 PPT elements with
purified RT’s. The results of these experiments suggest
that, even though some mutations in the PPT are toler-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 496 1810. E-mail: peden@cber.cber.fda.gov. ated, in many cases the efficiency of cleavage is reduced
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noncanonical PPT1. This sequence differs from the HIV-
2 consensus PPT1 in the arrangement of the purine resi-
dues (Myers et al., 1995), as well as being interrupted
by a single pyrimidine (Guyader et al., 1987) (Fig. 2A). We
determined the sequence of the PPT1 of two infectious
molecular clones of HIV-2ROD , pROD2, and pROD10 (Dan-
iel et al., 1988; Naidu et al., 1988; Ryan-Graham and
Peden, 1995). While this sequence was the same in these
two clones (Fig. 2A), it differed from the published HIV-
2ROD PPT in the number of A and G residues (Guyader
et al., 1987). The difference with the original sequence
is not understood but may be due to the difficulty in
reading runs of purines in sequencing gels.
Because three independent clones isolated from cells
infected with HIV-2ROD possessed a pyrimidine-inter-
rupted PPT1, it is likely that the predominant viruses cir-
culating in the patient had this variant PPT1. To assess
FIG. 1. Model of retroviral reverse transcription. (a) The DNA struc- the stability of the PPT1 in vitro, virus was prepared by
ture of the HIV provirus with its long terminal repeat (LTR; consisting transfection of 293 cells with the plasmid pROD10 and
of U3, R, and U5) elements. The cellular tRNA molecule that acts as used to infect the CEM and H9 T-cell lines at an approxi-
the initial primer for minus-strand DNA synthesis is annealed to the
mate multiplicity of infection (m.o.i.) of 0.01 (Peden andprimer binding site (PBS) of viral genomic RNA (thick line). (b) Minus-
Martin, 1995). Virus production was followed by the pres-strand strong-stop DNA (thin line) is created when synthesis reaches
the end of RNA template; the RNA in a duplex with DNA is degraded ence of RT activity in the medium. Virus was collected
(dashed line) by the virus-encoded RNaseH. (c) Minus-strand strong- at Day 10 after infection, which was at the time of peak
stop DNA is transferred to the 3* end of the genomic RNA and is RT activity in each of the cultures. The virus stocks from
extended along this template. The open rectangles represent the
their respective cultures were used to infect fresh CEMpolypurine tracts (PPT1 and PPT2), which are RNaseH-resistant RNA
and H9 cells at an m.o.i. of about 0.01. At the peak ofelements and become the plus-strand primers. (d) Plus-strand synthe-
sis commences from the polypurine tracts. PPT1 is found just upstream virus production, the medium was collected, and DNA
of the 3* LTR, and PPT2 is located approximately in the middle of the was prepared (Whetsell et al., 1992) from the cells. We
genome. (e) After the second (plus-strand) transfer, full-length viral DNA estimate from the growth curves (not shown) that these
is generated (f). Positions of the primers used for polymerase chain
two passages corresponded to between 10 and 20 virusreaction (PCR) amplification and sequencing of the two-LTR circular
generations (Dimitrov et al., 1993). The DNA was sub-DNA (see Fig. 2 legend for details) are designated by dotted arrows.
The primers 1 and 2 were used for the first round of PCR; the primers jected to PCR to amplify the PPT1 region followed by
3 and 4 was used for the second PCR amplification and for sequencing. PCR sequencing using the automated ABI fluorescent
dideoxy method (Lauermann and Boeke, 1994; Wei et al.,
1995).and the specificity relaxed. Purine residues close to the
3* end of the PPT appear to be critical, whereas those The results were unambiguous: the PPT1 was main-
tained after the second passage in both CEM and H9farther from the point of priming can be exchanged with
pyrimidines (Palaniappan et al., 1996; Powell and Levin, cells, and there was no evidence that the pyrimidine
residue mutated to a purine (Fig. 2C), demonstrating that1996; Pullen et al., 1993; Rattray and Champoux, 1989).
The activity of the mutant PPT1 elements was not as- a PPT1 containing a pyrimidine was functional for virus
replication.sessed with respect to virus replication. In this study,
we addressed the question of whether a virus with a Several factors need to be addressed if there is broad
biological relevance to our finding. The issue of whethernoncanonical, pyrimidine-interrupted PPT1 is able to rep-
licate and whether such a PPT is retained upon passage the HIV-2ROD noncanonical pyrimidine-interrupted PPT1
exists in vivo or is a result of in vitro passage in T-of the virus or if selection pressure would cause it to
revert to the canonical sequence. In addition, we have cell lines cannot be determined, as patient material is
unattainable. The following points taken collectively sug-determined the specificity of cleavage at the PPT1 by
RNaseH by sequencing the ends of the LTR elements in gest that it is likely that this PPT1 sequence was present
in the original virus. (1) The original isolate was obtainedunintegrated viral DNA.
HIV-2ROD was isolated from a west African male with by coculture of the patient’s peripheral blood mononu-
clear cells (PBMC) with uninfected activated PBMCAIDS (Clavel et al., 1986a). Three independent clones
have been isolated by different groups from CEM cells (Clavel et al., 1986a). Subsequently, this virus was found
to infect T-cell lines and infected CEM cells were theacutely infected with HIV-2ROD (Clavel et al., 1986b; Daniel
et al., 1988; Naidu et al., 1988; Ryan-Graham and Peden, source of the virus for the cloning of the viral genome
(Clavel et al., 1986b; Naidu et al., 1988). (2) Three inde-1995). The reported sequence of the ROD strain has a
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(with pyrimidines at different positions) have been found
in a few other molecular clones of HIV-2 and SIV; how-
ever, the stability of the PPT1 in those cases has not
been addressed.
It could be argued that not enough replication cycles
have been performed to allow reversion of the PPT1.
However, changes were found in the gag gene from
these passaged viruses (unpublished results), rendering
this contention unlikely.
Since the nef gene overlaps the PPT1, maintenance
of the PPT1 sequence could be due to selection either
for the PPT1 or for the overlapping gene. There are two
infectious molecular clones with this pyrimidine-con-
taining PPT1, one with the nef reading frame open,
pROD10, and the other carrying nef deletions, pROD2. In
this latter case, selection could only have involved the
PPT1. Deletions in the nef gene have been found in vivo
(Deacon et al., 1995; Kirchhoff et al., 1995) but to our
knowledge do not arise on passage in vitro. This sug-
gests that it is the particular combination of RNaseH and
the PPT1 for HIV-2ROD that had been selected for in vivo.
Introducing pyrimidines into the PPT can relax RNaseH
specificity (Palaniappan et al., 1996; Powell and Levin,
1996; Pullen et al., 1993; Rattray and Champoux, 1989).
Therefore, it was important to determine the specificity
of RNaseH cleavage for the pyrimidine-containing ROD
PPT1 during retrovirus replication. During productive in-
fection, not all of the linear viral DNA is integrated into
the host chromosome; some is converted to two-LTR
circular molecules, presumably by a cellular ligase. Be-
cause this ligation preserves the nucleotides normally
removed from the ends of the viral DNA during integra-
FIG. 2. Nucleotide sequences of the polypurine tracts of HIV-1 and HIV- tion (Hong et al., 1991; Kulkosky et al., 1990; Pauza, 1990;
2 and the two LTR circle junction of HIV-2ROD. (A) The sequences of the Smith et al., 1990; Whitcomb and Hughes, 1991; Whit-polypurine tracts of HIV-1 and HIV-2. The consensus sequences of the
comb et al., 1990), the sequence of the circle junctionPPT1 and PPT2 of HIV-1 and HIV-2 (Myers et al., 1995) as well as the
sequences of the PPT1 and PPT2 of HIV-2ROD are shown. The gap in the provides information about the ends of the linear viral
sequence of the PPT1 corresponds to the RNaseH cleavage site. The DNA. The left end of the viral genome is defined by the
corresponding amino acid sequence of the overlapping genes (nef for removal of the PPT primer by RNaseH. The DNA isolated
PPT1 and integrase for PPT2) are also shown. As explained in the text,
from the infected cultures was amplified by two roundsthe sequence of HIV-2ROD is different from the one in GeneBank (Accession
of PCR and subjected to direct sequencing. All sevenNo. M15390). (B) The circle junction sequence of HIV-2ROD . DNA was
prepared from infected cells, and the region containing the junctions was cultures in which junction sequences were analyzed had
amplified by two rounds of PCR using oligonucleotides VL7 5*-GGCAGG- five nucleotides between the LTR elements at the circle
CCTGACTTGTGCCC-3* and VL8 5*-GCACTTGGCCGGTGCTGGGC-3* fol- junction that are not present at the ends of the proviral
lowed by amplification with VL11 5*-GACGGCCCCACGCTTGCTTGC-3*
genome (Figs. 2B and 2C). These were the same fiveand JB1000 5*-TCTAAGTATATATTTAAGATTTTATGTCT-3*. The products
nucleotides found for the NIH-Z strain of HIV-2 (Whitcombwere sequenced directly using IBI sequencing system. The sequence of
part of the U5 and U3 regions is shown. The five nucleotides not found and Hughes, 1991), which has an all-purine and canoni-
at the ends of the proviral DNA are underlined, and the ends of the DNA cal PPT1 (Fig. 2A). Therefore, both types of PPT direct
are indicated with a colon. Incorrect cleavages were estimated to be no the same cleavages at the 3* end of the PPT. The analysis
more than 10%. (C) The region of the sequencing gel that shows the circle
of the sequence chromatograms of the pool of circlejunction. The background peaks seen on the right side of the chromato-
junctions suggests that the RNaseH cleavage is precise.gram are most likely not due to heterogeneity of the sequence, since
similar background differences were seen elsewhere in the chromatogram Based on this type of analysis (Wei et al., 1995), we
(not shown). estimate that incorrect cleavages can be no more than
10% of the total cleavage events. This is similar to the
proportion of aberrant LTR–LTR junctions seen pre-pendent clones of HIV-2ROD were all found to have the
noncanonical pyrimidine-interrupted PPT1. (3) Similar viously with HIV-1 (Whitcomb et al., 1990) and HIV-2
(Whitcomb and Hughes, 1991).noncanonical pyrimidine-interrupted PPT1 elements
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strand strong-stop DNA synthesis in retrotransposon Ty1. J. Virol.In summary, we have shown: (1) that a noncanonical
69, 7845–7850.pyrimidine-interrupted PPT1 is fully functional for HIV rep-
Lauermann, V., Peden, K. W. C., and Boeke, J. D. (1996). Alternative
lication in vitro; (2) there was no reversion to an all-purine tRNA primers for HIV. AIDS 47, 15–17.
PPT1 after two passages on two T-cell lines, CEM and Luciw, P. A. (1996). Retroviridae: The Viruses and Their Replication. In
‘‘Fields Virology’’ (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.),H9; and (3) this noncanonical PPT1 appears to direct the
Vol. 2, pp. 1881–1952. Lippincott-Raven, Philadelphia, PA.same 3* cleavage specificity as an all-purine PPT1.
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